Self-administered injectable medicines should be considered for reclassification as Pharmacy (P) medicines, the chief ...
Boots retail operations in the UK and Ireland will be acquired by Wittington Investments, the holding company of the Weston ...
A 2020 review led by Baroness Julia Cumberlege examined concerns raised by patients and families about the safety of medicines and medical devices. The review described doctors in the 1950s to 1970s ...
“The prediction is [that] by 2035, up to 50% of healthcare decisions will involve a genomic result of some sort,” Vicky Chaplin, senior clinical lead for the genomics unit at NHS England, told ...
Women exposed to glucagon-like peptide-1 (GLP-1) receptor agonists around conception did not have a “clearly detectable ...
A case-finding to medicines optimisation approach for pharmacy diagnosis and treatment of hypertension demonstrates that long-term conditions can be managed in community pharmacies safely and ...
All health boards in Wales have been told to nominate a senior member of their pharmacy team to be responsible for advanced ...
The General Pharmaceutical Council (GPhC) has failed to meet the Professional Standards Authority’s (PSA) standard on the ...
Since the approval of semaglutide (Wegovy; Novo Nordisk) as a weight-loss injection in the United States in 2021, the effect of GLP-1 medicines on the treatment of obesity has been undeniable. In the ...
One night in March 2025, Kate got a call from the hospital around 1 am to say her son was being moved from the ward into the intensive care unit. “[I thought] they were going to go, yeah, we just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results